March 4 (Reuters) - Genetic Technologies Ltd (GTG) :
- GENETIC TECHNOLOGIES SIGNS MULTI-YEAR US DISTRIBUTION AGREEMENT FOR COVID RISK TEST
- GENETIC TECHNOLOGIES LTD - CO SIGNS CO-EXCLUSIVE PRODUCTION AND DISTRIBUTION RIGHTS AND LICENSE AGREEMENT WITH INFINITY BIOLOGIX LLC
- GENETIC TECHNOLOGIES LTD - IBX IS REQUIRED TO MAKE MINIMUM PAYMENTS TO CO TOTALING US$2.9 MILLION OVER TERM TO MAINTAIN EXCLUSIVITY
- GENETIC TECHNOLOGIES LTD - UNDERLYING ROYALTY STRUCTURE IS ON A PER UNIT BASIS OF US$10
- GENETIC TECHNOLOGIES LTD - IBX WILL DEFINE AND DECIDE SALES AND END-TO-CONSUMER PRICING STRUCTURE FOR COVID-19 RISK TEST
- GENETIC TECHNOLOGIES LTD - GTG TEAM IS IN FINAL STAGES TO SUBMIT COVID-19 RISK TEST FOR CLEARANCE FROM CLINICAL LABORATORY IMPROVEMENT AMENDMENTS
- Forums
- ASX - By Stock
- GTG
- News: GTG Genetic Technologies Signs Multi-Year US Distribution Agreement For COVID Risk Test
News: GTG Genetic Technologies Signs Multi-Year US Distribution Agreement For COVID Risk Test
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
|
|||||
Last
10.0¢ |
Change
0.006(6.38%) |
Mkt cap ! $13.22M |
Open | High | Low | Value | Volume |
9.5¢ | 10.0¢ | 9.5¢ | $1.257K | 12.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 45978 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 101386 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 45978 | 0.094 |
2 | 60700 | 0.093 |
2 | 53778 | 0.092 |
1 | 20000 | 0.091 |
5 | 46919 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 101386 | 6 |
0.105 | 53674 | 5 |
0.110 | 4118 | 1 |
0.120 | 7215 | 1 |
0.125 | 68049 | 2 |
Last trade - 10.09am 17/06/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online